April 22, 2025 06:38 AM EDTUpdated 11:32 AM
Pharma
Manufacturing

Up­dat­ed: Roche’s $50B US in­vest­ment in­cludes pre­vi­ous build an­nounce­ments

Anna Brown

News Reporter

Roche is the lat­est phar­ma gi­ant to ear­mark bil­lions of dol­lars to boost its R&D and man­u­fac­tur­ing pres­ence in the US, with an es­ti­mate of …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

VP, Clinical Development / CMO / CDO‬ ‭ (Stealth Portfolio Company)

Autonomy Bio Inc.

San Francisco, CA 94107, USA

TRENDING NOW

As the XBI suf­fers, Q1 shows a few com­fort­ing signs of un­der­ly­ing sta­bil­i­ty

Gala­pa­gos CEO Paul Stof­fels to step down, for­mer Neumo­ra chief to lead spin­out

Drug­mak­ers stock­pile in­ven­to­ry in the US, seek­ing to get ahead of Trump tar­iffs

Ex­clu­sive: George Church start­up will study long-lived an­i­mals, hu­mans to find life-ex­tend­ing genes

Makary, in one of first com­ments on FDA pol­i­cy, floats new path­way for rare dis­ease drugs

sponsored

AD­STI­LADRIN® (nad­o­fara­gene fi­rade­n­ovec-vncg) – A Grow­ing Body of Clin­i­cal Da­ta and Re­al-World Ev­i­dence

A service from the Financial Times